Intervention

Selexipag

ClinicalTrials.gov intervention label

Clinical trials13
Recruiting1
Common conditions8
Lead sponsors shown3

Clinical trials

13 shown
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other OptionNCT05179876 · 2022-05-04
RECRUITING
Patient-Reported Outcomes and Adherence After Transition From Inhaled Iloprost to Oral Selexipag in Pulmonary Arterial HypertensionNCT07356375 · 2026-03-01
NOT_YET_RECRUITING
Pulmonary Hypertension: Intensification and Personalisation of Combination RxNCT05825417 · 2023-06-14
ACTIVE_NOT_RECRUITING
A Study of Selexipag in Participants Who Participated in a Previous Selexipag StudyNCT04565990 · 2021-05-03
COMPLETED
A Study in Participants With Sarcoidosis-associated Pulmonary Hypertension (SAPH) to Assess the Efficacy and Safety of Oral SelexipagNCT03942211 · 2021-02-26
TERMINATED
Selexipag for the Treatment of Schistosomiasis-Associated Pulmonary Arterial HypertensionNCT04589390 · 2020-10-15
UNKNOWN
A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial HypertensionNCT04175600 · 2020-01-16
ACTIVE_NOT_RECRUITING
A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional TreatmentNCT03689244 · 2019-01-23
TERMINATED
Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension.NCT03078907 · 2017-11-08
COMPLETED
The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial HypertensionNCT02558231 · 2016-05-01
COMPLETED
Study to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Patients With Pulmonary Arterial HypertensionNCT02471183 · 2015-10-12
COMPLETED
Effects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic SclerosisNCT02260557 · 2014-10-31
COMPLETED
Selexipag (ACT-293987) in Pulmonary Arterial HypertensionNCT01106014 · 2009-12-01
COMPLETED

Trial status mix

COMPLETED6
ACTIVE_NOT_RECRUITING2
TERMINATED2
NOT_YET_RECRUITING1
RECRUITING1
UNKNOWN1

Phase mix

PHASE37
PHASE23
PHASE42

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.